Synthesis and biological evaluation of some stilbene derivatives

Medicinal Chemistry Research

Volumn 20, Issue 8, 2011, Pages 1349-1356

  Karki, Subhas Somalingappa ^a   Bhutle, Santosh Ramarao ^a   Sahoo, Subhas ^a   Reddy, Ratnakar ^a   Balzarini, Jan ^b   De Clercq, Erik ^b   Darji, Satyanarayana Y ^a  

^a A Constituent Unit of KLE Academy of Higher Education Research   (India)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Cytostatic; Olefine; Schiff; Stilbenes

Indexed keywords

CYTOSTATIC AGENT; STILBENE DERIVATIVE;

ARTICLE; CANCER INHIBITION; CIS TRANS ISOMERISM; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; INFRARED RADIATION; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; TUMOR GROWTH;

EID: 80054756074     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9484-1     Document Type: Article

References (18)

1. Baraldi PG, Del Carmen Nunez M, Tabrizi MA, De Clercq E, Balzarini J, Bermejo J, Estévez F, Romagnoli R (2004) Design, synthesis, and biological evaluation of hybrid molecules containing a-methylene-c- butyrolactones and polypyrrole minor groove binders. J Med Chem 47:2877-2886 (Pubitemid 38656741)
2. Chang TK, Lee WB, Ko HH (2000) Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogenactivating human cytochrome P450 1B1. Can J Physiol Pharmacol 78:874-881
3. Chun YJ, Kim MY, Guengerich FP (1999) Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262:20-24 (Pubitemid 29412616)
4. Chun YJ, Ryu SY, Jeong TC, Kim MY (2001) Mechanism based inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metab Dispos 29:389-393 (Pubitemid 32275551)
5. Cushman M, Nagarathnam D, Gopal D, He HM, Lin CM, Hamel E (1992) Synthesis and evaluation of analogs of (Z)-1-(4-methoxyphenyl)-2-(3, 4, 5-trimethoxyphenyl) ethene as potential cytotoxic and antimitotic agents. J Med Chem 35:2293-2306
6. Dong Z (2003) Molecular mechanism of the chemopreventive effect of resveratrol. Mutation Res 523-524:145-150 (Pubitemid 36293241)
7. Ekena K, Katzenellenbogen JA, Katzenellenbogen BS (1998) Determinants of ligand specificity of estrogen receptor-alpha: Estrogen versus androgen discrimination. J Biol Chem 273:693-699 (Pubitemid 28049154)
8. Fontecave M (1998) Ribonucleotide reductases and radical reactions. Cell Mol Life Sci 54:684-695 (Pubitemid 28379670)
9. Gao H, Katzenellenbogen J, Garg R, Hansch C (1999) Comparative QSAR analysis of estrogen receptor ligands. Chem Rev 99: 723-744
10. Heynekamp JJ, Weber WM, Hunsaker LA, Gonzales AM, Orlando RA, Deck LM, Jagt DL (2006) Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J Med Chem 49(24): 7182-7189 (Pubitemid 44886003)
11. Jang M, Pezzuto JM (1999) Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res 25:65-77 (Pubitemid 29257597)
12. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220 (Pubitemid 127696281)
13. Lion CJ, Matthews CS, Stevens MF, Westwell AD (2005) Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes. J Med Chem 48(4):1292-1295 (Pubitemid 40270477)
14. Moran BW, Anderson FP, Devery A, Cloonan S, Butler WE, Varughese S, Draper SM, Kenny PT (2009) Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol. Bioorg Med Chem 17(13):4510-4522
15. Sadler BR, Cho SJ, Ishaq KS, Chae K, Korach KS (1998) Threedimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach. J Med Chem 41:2261-2267 (Pubitemid 28285728)
16. Sangjun S, de Jong E, Nijmeijer S, Mutarapat T, Ruchirawat S, van den Berg M, van Duursen MB (2009) Induction of cell cycle arrest in human MCF-7 breast cancer cells by cis-stilbene derivatives related to VIOXX. Toxicol Lett 186(2):115-122
17. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L et al (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276:22586-22594
18. Wright JS, Johnson ER, Dilabio GA (2001) Predicting the activity of phenolic antioxidants: Theoretical method, analysis of substituent effects, application to major families of antioxidants. J Am Chem Soc 123:1173-1183 (Pubitemid 32148182)